ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: FR-PO709

Mutation in Transient Receptor Potential Cation Channel Subfamily C Member 6 (TRPC6) Regulates Yes-Associated Protein 1(YAP1) Phosphorylation

Session Information

Category: Glomerular Diseases

  • 1304 Glomerular Diseases: Podocyte Biology

Authors

  • Chou, Chia An, Bristol Renal, Department of Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
  • Saleem, Moin, Bristol Renal, Department of Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
  • Welsh, Gavin Iain, Bristol Renal, Department of Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
Background

Transient receptor potential cation channel, subfamily C member 6 (TRPC6), is a cation channel associated with hereditary focal segmental glomerulosclerosis. Angiotensin II(Ang II) activates TRPC6 and its downstream signalling. We investigated signalling regulated by TRPC6 in podocytes to understand the disease pathogenesis.

Methods

We developed conditionally immortalized wild-type and TRPC6-knockout (T6K) podocytes. Lentiviral transduction was used to express GFP-tagged TRPC6 in T6K cells. Phosphoproteomic analysis was used to identify changes in signalling pathways mediated by knocking out TRPC6. Immunoblotting and quantitative reverse transcription PCR (RT-qPCR) were applied for validation.

Results

T6K podocytes showed increased phosphorylation of Yes-associated protein (YAP) compared with the control. Ang II treatment increased YAP phosphorylation in control podocytes but not in T6K. RT-qPCR showed decreased expression of connective tissue growth factor (CTGF) and cellular communication Network Factor 1 (CCN1), YAP downstream transcriptional targets, which returned to control levels upon expression of TRPC6GFP in T6K.

Conclusion

TRPC6 regulates the YAP phosphorylation and its downstream targets' level in podocytes. YAP is a transcriptional factor controlling cell proliferation. Our experiments suggest that knocking-out TRPC6 increases YAP phosphorylation and inhibits YAP-induced transcription.

Immunoblotting of p-YAP in T6K and control podocytes.
Cells were treated by 0.1 uM ANG II with various duration.

RT-qPCR of CTGF and CCN1 levels in WT, T6K and T6K+TRPC6GFP cell lines. Graphs represent mean±SEM. WT: wild-type; T6K: TRPC6 Knockout, T6K+TRPC6GFP:T6K transduced with GFP-tagged TRPC6.

Funding

  • Private Foundation Support